Diana C. Dinh, MD

Associate Professor of Radiology
Beth Israel Deaconess Medical Center, United States

Disclosure information not submitted.

Presentation(s):

• 71 - Changing Utilization of Locoregional Therapies for HCC Across the United States

  Sunday, April 12, 2026
  3:00 PM - 3:09 PM ET

• 72 - Target Trial Emulation: A Comparison of Resection, Ablation, and TARE for Early-Stage HCC – a Real-World Analysis

  Sunday, April 12, 2026
  3:09 PM - 3:18 PM ET

• 571 - Can Hospital Volume of TARE Affect Survival in Early-stage HCC ?

  Monday, April 13, 2026
  12:10 PM - 1:10 PM ET

• 115 - Socioeconomic Factors Influencing Treatment Receipt of HCC : A Nationwide Analysis

  Monday, April 13, 2026
  3:54 PM - 4:03 PM ET

• 183 - Comparative Voxel-Based Dosimetry of Underdosed Tumor Volume and Tumor Absorbed Dose Between Tc-MAA SPECT/CT and 90Y PET/CT in HCC Patients Treated with Radiation Segmentectomy

  Monday, April 13, 2026
  3:45 PM - 3:54 PM ET

• 246 - Comparison of Size- and Enhancement-Based Criteria for Evaluating Treatment Response and Survival Outcomes in Intrahepatic Cholangiocarcinoma Patients Treated with Yttrium-90 Radioembolization

  Tuesday, April 14, 2026
  3:00 PM - 3:09 PM ET

• 251 - Voxel-based Dosimetry and Activity Deposition Pattern Predicting Survival and Progression Outcomes in Intrahepatic Cholangiocarcinoma Patients Treated with Yttrium-90 Radioembolization Using Resin Microspheres

  Tuesday, April 14, 2026
  3:45 PM - 3:54 PM ET

• 355 - Histopathologic Analysis of Intrahepatic Cholangiocarcinoma Treated with Transarterial Radioembolization Using Yttrium-90 Resin Microspheres

  Wednesday, April 15, 2026
  11:24 AM - 11:33 AM ET

• 356 - Volume of Under-Dosed Tumor Predicts Survival After Radiation Segmentectomy of Hepatocellular Carcinoma Using Resin Microspheres

  Wednesday, April 15, 2026
  11:33 AM - 11:42 AM ET